✦ LIBER ✦

Cost‐Effectiveness of Testing for Human Immunodeficiency Virus and Hepatitis C Virus Among Blood Transfusion Recipients •

✍ Scribed by Simone Mathoulin‐Pelissier, MD, PhD; Louis‐Rachid Salmi, MD, PhD; Pierre Fialon, MD; Roger Salamon, MD, PhD

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The cost-effectiveness of introducing nu

✍ Thomas Davidson; Bengt Ekermo; Hans Gaines; Birgitta Lesko; Britt Åkerlind 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Prevalence and risk factors of hepatitis

✍ Gloria M. Calderón; Felipe González-Velázquez; Cesar R. González-Bonilla; Bárbar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 91 KB

PHP26 COST-EFFECTIVENESS OF SCREENING DO

✍ D Grima; D Marshall; M Weinstein; J Wong; S Kleinman; J AuBuchon 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Residual risk of transfusion transmitted

✍ C. R. Seed; P. Kiely; A. J. Keller 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Blood donor screening with nucleic acid

✍ S. Kleinman 📂 Article 📅 2008 🏛 Blackwell Publishing ⚖ 80 KB

IN2 COST-EFFECTIVENESS (CE) OF SCREENING

✍ DT Grima; D Marshall; M Weinstein; JB Wong; S Kleinman; J AuBuchon 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB